Stock QPT QUEST PHARMATECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Quest PharmaTech Inc.

Equities

QPT

CA74836M1068

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 09:49:37 2024-04-25 EDT 		5-day change 1st Jan Change
0.02 CAD -42.86% Intraday chart for Quest PharmaTech Inc. -42.86% -63.64%
01-30 Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes MT
01-30 Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000 MT

Valuation

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Capitalization 1 17.54 26.78 19.25 32.76 15.14 11.84
Enterprise Value (EV) 1 5.751 23.32 19.54 32.87 15.39 12.46
P/E ratio -3.28 x -6.09 x -3.11 x 0.18 x -0.18 x -1.61 x
Yield - - - - - -
Capitalization / Revenue 451 x - - - - -
EV / Revenue 148 x - - - - -
EV / EBITDA -0.73 x -2.58 x -1.43 x -30.8 x -19.5 x -15.2 x
EV / FCF 1.13 x -5.91 x 13.8 x -1.83 x -138 x -21 x
FCF Yield 88.2% -16.9% 7.22% -54.6% -0.72% -4.76%
Price to Book -2.38 x -2.61 x -1.26 x 0.19 x 0.17 x 0.14 x
Nbr of stocks (in thousands) 167,089 167,389 167,389 167,999 168,239 169,129
Reference price 2 0.1050 0.1600 0.1150 0.1950 0.0900 0.0700
Announcement Date 18-05-31 19-05-30 20-06-26 21-05-31 22-05-26 23-05-31
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Net sales 1 0.0389 - - - - -
EBITDA 1 -7.842 -9.034 -13.63 -1.068 -0.7887 -0.8207
EBIT 1 -7.854 -9.042 -13.63 -1.07 -0.7906 -0.8342
Operating Margin -20,204.72% - - - - -
Earnings before Tax (EBT) 1 -9.112 -8.641 -13.25 190.1 -85.04 -7.332
Net income 1 -5.086 -4.393 -6.184 190.1 -85.04 -7.332
Net margin -13,084.82% - - - - -
EPS 2 -0.0320 -0.0263 -0.0369 1.112 -0.5055 -0.0435
Free Cash Flow 1 5.073 -3.946 1.411 -17.96 -0.1112 -0.5933
FCF margin 13,051.71% - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-05-31 19-05-30 20-06-26 21-05-31 22-05-26 23-05-31
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 0.29 0.11 0.25 0.63
Net Cash position 1 11.8 3.46 - - - -
Leverage (Debt/EBITDA) - - -0.021 x -0.0986 x -0.3165 x -0.7619 x
Free Cash Flow 1 5.07 -3.95 1.41 -18 -0.11 -0.59
ROE (net income / shareholders' equity) -135% 1,152% 127% 239% -64% -8.44%
ROA (Net income/ Total Assets) -40.7% -60.8% -166% -0.74% -0.37% -0.59%
Assets 1 12.51 7.227 3.723 -25,581 22,946 1,233
Book Value Per Share 2 -0.0400 -0.0600 -0.0900 1.040 0.5400 0.4900
Cash Flow per Share 2 0 0 0.0100 0 0 0
Capex 1 0.01 0 - - - -
Capex / Sales 22.44% - - - - -
Announcement Date 18-05-31 19-05-30 20-06-26 21-05-31 22-05-26 23-05-31
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUEST PHARMATECH INC. Stock Quest PharmaTech Inc.
-63.64% 2.47M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. QPT Stock
  4. Financials Quest PharmaTech Inc.